Latest News
Ministerial Working Visit to NIPRDWebinar Conference on Expediting Local Vaccines’ Manufacturing in NigeriaPharma Industry Engagement (WHO PQ Capacity Building Programme)NIPRD signs MoU with FMSDIGA and NLTF on CPPInternational Conference on Health Access and Socio-Economic Development Beyond COVID-19 (ASICC-19)

Analytical Research
Contextualizing Research Processes
Ministerial Working Visit
Dr Tunji Alausa, Hon Minister of State for Health and Social Welfare with Dr Obi Adigwe, DG NIPRD
Robust Engagement
Dr Obi Adigwe, DG NIPRD presenting ASICC-19 documents to Vice President, Prof. Yemi Osinbajo
Partnership Development
Dr Adigwe presenting a Business Feasibility Plan on CPP to the Kaduna State Government
NIPRD Laboratory Complex
Head office of the National Institute for Pharmaceutical Research and Development
International Collaboration
Chief Diana Chen, Chair CABC Collaborative Visit to DG NIPRD
Partnership Engagement
Robust Inter-governmental Agency Collaboration
Pharma Industry Engagement
WHO PQ Capacity Building Programme
High-Level Dialogue
Ministerial Engagement to address tech gaps in Nigeria's Pharmac and Vaccine industries
Previous slide
Next slide

Welcome message from the Director-General / CEO

The National Institute for Pharmaceutical Research and Development (NIPRD) is a Federal Government Parastatal under the Federal Ministry of Health. The Agency was established by Government Order No. 33 Vol. 74 of 11th June 1987 Part B under the Science and Technology Act Cap 276. It became functional in the year 1989. In 2001 following a Federal Executive Council decision, NIPRD was moved to the Federal Ministry of Health (FMOH), with a huge investment in scientific equipment and human resources. 

NIPRD is the only one of its kind in the Region, and is statutorily charged with the responsibility for research and development of drugs, vaccines, phytomedicines, commodities, and diagnostics aimed at improving sustainable access to safe, affordable and high-quality healthcare. Read more…
Latest Media Engagement
"Part of Mr President’s aim in approving the “Unlocking Healthcare Value Chain Initiative”, as part of Nigeria’s Health Sector Renewal Programme, is to optimize end-to-end R&D pathways for addressing priority diseases in Nigeria."
Prof Muhammad Ali Pate
Prof Muhammad Ali PateCoordinating Minister of Health and Social Welfare, Nigeria
"We are now poised to moving the Healthcare sector from just a consuming part of the economy to growth-driven economy, through innovative R&D activities."
Dr Tunji Alausa
Dr Tunji AlausaHon. Minister of State for Health and Social Welfare, Nigeria
"We will do our very best to give legislative backing to enable you perform your duties."
Sen. Dr. Ipalibo Banigo
Sen. Dr. Ipalibo BanigoChair, Senate Committee on Health (Secondary and Tertiary)
Previous
Next

Get our COVID-19 Advisory

NSP-II and M&E Plan (2021 - 2025)

Previous
Next
MEDIA

Recent Blogs

Ministerial Working Visit to NIPRD

December 26, 2023 No Comments

Dr. Tunji Alausa, the Honourable Minister of State for Health and Social Welfare recently visited the National Institute for Pharmaceutical Research and Development (NIPRD) as

Read More »

Africa no longer has an interest in tokenistic interventions such as fill-finish products, but has become interested in building dependable, equitable, and veracious partnerships that will enable the Continent to undertake full R&D for the production of vaccines.

Dr Obi Adigwe, DG NIPRD Tweet

Our Partners ... The list keeps growing !

AEFU-NAI
Coat of Arm[2]
FUD
Katsina State Govt
KDSG
M&B
Malaria Consortium
NAPSSA
NCC
USP
WAHO

Useful Links

e-Herbarium
FOI Act
JOPAT
Publications